Provided by Tiger Trade Technology Pte. Ltd.

JPMORGAN HEALTHCARE LEADERS ETF

62.60
-0.1731-0.28%
Post-market: 62.770.1731+0.28%16:10 EDT
Volume:71
Turnover:4K
Market Cap:9.39M
PE:- -
High:62.60
Open:62.77
Low:62.60
Close:62.77
52wk High:64.69
52wk Low:50.34
Shares:150.00K
Float Shares:150.00K
Volume Ratio:0.10
T/O Rate:0.05%
Dividend:0.51
Dividend Rate:0.82%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly - Taltz and Zepbound Lead to Deeper Improvements in Systemic Inflammation in Both Trials

THOMSON REUTERS
·
Yesterday

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Used Together Showed Improved and Durable Efficacy at One Year in Adults with Psoriatic Disease and Obesity

THOMSON REUTERS
·
Yesterday

Eli Lilly - Taltz and Zepbound Maintain or Improve Disease Activity at Week 52 Versus Taltz Alone

THOMSON REUTERS
·
Yesterday

Eli Lilly: Adverse Events in Participants Treated with Taltz and Zepbound Together were Generally Mild to Moderate

THOMSON REUTERS
·
Yesterday

Lilly to Acquire Merida Biosciences in Deal Worth up to USD 2.88 Billion

Reuters
·
Yesterday

Eli Lilly: Under Terms of Agreement, Lilly Will Acquire Merida and Pay up to $2.875 Bln in Cash

THOMSON REUTERS
·
Yesterday

Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases

THOMSON REUTERS
·
Yesterday

Eli Lilly - Deal Expected to Close in Q4 2026 Subject to Regulatory Approvals

THOMSON REUTERS
·
Yesterday

Chimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities

TIPRANKS
·
Yesterday

ASX listed pharma boosted by weight loss drugs

Morning Star AU
·
Yesterday

UnitedHealth Group (UNH), Why Is The Market Paying Closer Attention Now?

Simply Wall St.
·
Aug 30

UnitedHealth, Strategy, Home Depot, Rocket Lab, Applied Shock

TIPRANKS
·
Aug 29

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

India's GLP-1 Weight-Loss Drugs Stall at $14 Monthly Despite High Diabetes Rates

Deep News
·
Aug 29

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 29

US FDA - Approves Stelara for Pediatric Ulcerative Colitis

THOMSON REUTERS
·
Aug 29

AbbVie Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Eli Lilly (LLY) Wins FDA Approval For Mounjaro Heart Risk Reduction

Simply Wall St.
·
Aug 29

AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan

TIPRANKS
·
Aug 29

Life Time CEO Sees GLP-1s as Positive for Health Clubs

Dow Jones
·
Aug 28